The purpose of this trial is to determine whether stem cell transplant using haplo-identical related donors is safe, effective, and cost worthy in treating people with sickle cell disorder compared with the standard of care treatment.
Stem cell transplant from a haplo-identical donor is not currently available on the NHS and can only be accessed through this research study.
Read more: https:// www.redresstrial.co.uk /about
